Neuphoria Completes Re-domiciliation and Successor Listing on Nasdaq

On December 23, 2024 Neuphoria Therapeutics Inc. (Nasdaq: NEUP) ("Neuphoria" or the "Company") reported that its previously announced scheme of arrangement in relation to Bionomics Limited’s proposed re-domiciliation from Australia to the United States, under which Neuphoria will become the ultimate parent company of Bionomics Limited, has been implemented today, December 23, 2024 New York time (December 24, 2024 Sydney time).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The shares of common stock of Neuphoria ("Neuphoria Shares") issued today in connection with the re-domiciliation are expected to commence trading on The Nasdaq Stock Market LLC under the symbol "NEUP" on December 24, 2024 or as soon as possible thereafter.

In addition, Neuphoria will issue options to acquire shares of common stock in Neuphoria ("Neuphoria Options") to holders of options to acquire shares in Bionomics ("Bionomics Options") that were issued by Bionomics, in exchange for their Bionomics Options. Neuphoria will also issue a warrant to purchase 1,054,381 shares of common stock in Neuphoria ("Neuphoria Warrant") to an institutional investor that holds a warrant to purchase 12,652,572 American Depositary Shares ("ADSs") of Bionomics ("Bionomics Warrant"), in exchange for the Bionomics Warrant.

Further details regarding the implementation of the redomiciliation can be found in a Current Report on Form 8-K that will be filed by Neuphoria with the SEC.

(Press release, Neuphoria Therapeutics, DEC 23, 2024, https://ir.neuphoriatx.com/news-releases/news-release-details/neuphoria-completes-re-domiciliation-and-successor-listing?utm_source=chatgpt.com [SID1234669413])